ketoconazole has been researched along with ppi 2458 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arico-Muendel, CC; Belanger, B; Benjamin, D; Blanchette, HS; Caiazzo, TM; Centrella, PA; DeLorey, J; Doyle, EG; Gradhand, U; Griffin, ST; Hill, S; Labenski, MT; Morgan, BA; O'Donovan, G; Prasad, K; Skinner, S; Taghizadeh, N; Thompson, CD; Wakefield, J; Westlin, W; White, KF | 1 |
1 trial(s) available for ketoconazole and ppi 2458
Article | Year |
---|---|
Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in vivo activity.
Topics: Aminopeptidases; Angiogenesis Inhibitors; Animals; Drug Administration Schedule; Epoxy Compounds; Humans; Leukocytes; Lymph Nodes; Lymphoma, Non-Hodgkin; Metalloendopeptidases; Microsomes, Liver; Rats; Structure-Activity Relationship; Thymus Gland; Valine | 2013 |